NervGen Pharma announces participation in investor conferences, CEO Adam Rogers to attend. TSXV: NGEN, NASDAQ: NGEN.
NervGen Pharma Corp., a biopharmaceutical company based in Vancouver, British Columbia, revealed today that its President and CEO, Adam Rogers, MD, along with other executives, will be attending various investor conferences in the near future. The company, listed on both TSXV (under the ticker NGEN) and NASDAQ (under the same ticker symbol), specializes in developing innovative treatments for spinal cord injuries and other neurotraumatic conditions. This announcement was made on February 18, 2026.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments